The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not.

[1]  R. Collins,et al.  Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab , 2000, Journal of the American College of Cardiology.

[2]  A. Cohen-Solal,et al.  Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. , 1998, Circulation.

[3]  J. Kjekshus,et al.  Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1997, The American journal of cardiology.

[4]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[5]  Therapy Study Investigators.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.

[6]  B. Pitt.  Use of converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction. , 1993, Journal of the American College of Cardiology.

[7]  W. Rudolph,et al.  Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. , 1992, Journal of the American College of Cardiology.

[8]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[9]  K. Swedberg,et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.

[10]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[11]  L. Hillis,et al.  The use of aspirin in ischemic heart disease. , 1992, The New England journal of medicine.

[12]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[13]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[14]  Y. Pirson,et al.  Renal side effects of nonsteroidal antiinflammatory drugs: clinical relevance. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  C. Dollery,et al.  Interaction of nonsteroidal anti-inflammatory drugs with antihypertensive and diuretic agents. Control of vascular reactivity by endogenous prostanoids. , 1986, The American journal of medicine.

[16]  J. Stamler,et al.  Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.

[17]  M. Packer,et al.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.

[18]  M. Vallotton,et al.  Interaction of diuretics and non-steroidal anti-inflammatory drugs in man. , 1983, Clinical science.

[19]  K. Silberbauer,et al.  Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. , 1982, British journal of clinical pharmacology.

[20]  R. Zusman.  Prostaglandins, vasopressin, and renal water reabsorption. , 1981, The Medical clinics of North America.

[21]  J. Handler.  Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water. , 1981, Kidney international.

[22]  A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.

[23]  K. Berg,et al.  Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs. , 1977, Scandinavian journal of clinical and laboratory investigation.

[24]  R. Kimberly,et al.  Aspirin-induced depression of renal function. , 1977, The New England journal of medicine.